Follow-on Roundup: Arrowhead, Kodiak, Relmada, Revance

Since market close on Tuesday, Arrowhead, Kodiak, Relmada and Revance raised a total of $718.5 million in follow-ons.

Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) raised $232 million after it priced an

Read the full 287 word article

User Sign In